biotech · Relapsed or Refractory B-cell Malignancies · Solid Tumor · RXRX
RECURSION PHARMACEUTICALS
RECURSION PHARMACEUTICALS, INC.
RECURSION PHARMACEUTICALS is a biotech organization headquartered in Staten Island, USA. It trades on NYSE under ticker RXRX. Primary therapeutic focus areas include Relapsed or Refractory B-cell Malignancies, Solid Tumo
Staten Island, USA HQ
11 Employees
Public company Type
RXRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Staten Island, USA
- Employees
- 11
- Programs
- 9
- Drugs
- 2
- Patents
- 4
REC-2282
Phase 3 · small molecule · Neurofibromatosis Type 2
REC-2282 for Neurofibromatosis Type 2 is a Phase 3 program (small_molecule) at RECURSION PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Internal code REC-2282-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- RECURSION PHARMACEUTICALS, INC.
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Neurofibromatosis Type 2
- Status
- terminated
- Trials
- 1